6/30 In Vitro
et al., Antiviral Research, doi:10.1016/j.antiviral.2020.104787 (Peer Reviewed) (In Vitro)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
In Vitro study showing that ivermectin is an inhibitor of SARS-CoV-2, with a single addition to Vero-hSLAM cells 2h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48h.
Caly et al., 6/30/2020, peer-reviewed, 5 authors.
